SecBot SecBot
Insider Cluster (5 insiders) ·Filed Aug 5, 2026

TWST

Twist Bioscience Corp
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago
Insider cluster: 2 insiders, $106K total
Actionable Insight • Neutral

The insider sales are trivial in size and coincide with a strong earnings beat-and-raise. No bearish signal, the cluster is likely driven by post-earnings window opening and routine diversification. Monitor for any larger-scale selling in the coming weeks, but this cluster alone does not warrant action.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$109.08
T+0 close · Aug 5, 2026 · via day close
Latest settled
+59.01%
T+60 · $173.45
Vs SPY
+60.44%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 6 $109.08entry
  2. T+1 · 3mo ago +6.04%α +5.43% · $115.67
  3. T+5 · 3mo ago +14.86%α +13.65% · $125.29
  4. T+20 · 2mo ago +18.00%α +17.40% · $128.71
  5. T+60 · 17d ago +59.01%α +60.44% · $173.45
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Five Twist Bioscience insiders, including CEO Emily Leproust and President/COO Patrick Finn, sold a combined $884K in open-market shares on August 3, 2026, the same day the company reported a strong fiscal Q3 2026 beat-and-raise earnings. The cluster is entirely composed of sales, totaling ~0.01% of the $7.2B market cap, which is below the 0.1% materiality threshold and thus routine. The sales are likely driven by the post-earnings blackout window opening and pre-planned 10b5-1 programs, not a bearish signal on fundamentals.

Key Financial Metrics

Direction
selling
Total Value
$884.0K
Insiders
5

Key Facts

  • Five insiders sold shares on August 3, 2026, at $85.32 each.
  • Total open-market sales: $884K.
  • Sales represent ~0.01% of Twist's $7.2B market cap.
  • CEO Leproust sold $435K; President/COO Finn sold $246K.
  • Earnings released same day: Q3 FY2026 revenue $118.4M (beat), guidance raised to $456-457M.
  • All sales are open-market (code S), no derivative exercises or tax-withholding transactions.

Financial Impact

$884K in insider sales, immaterial relative to $7.2B market cap.

insider ownershipfloat

Risk Factors

  • Insiders may continue selling in larger volumes after the blackout window fully opens.
  • The cluster is entirely sells, which could be misinterpreted by the market as negative.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
94% bullish (16 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-TWST-1786004096453

US Market Status

Market Closed · Opens Tue (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 6, 2026